The pre‐efficacy phase testing for PAfitME™—A behavioral physical activity intervention to manage moderate and severe symptoms among advanced stage cancer patients
| Autor: | Tapan A. Padhya, Laura A. Szalacha, Jaelyn D. Brown, Kristine A. Donovan, Hsiao-Lan Wang, Harleah G. Buck, Barbara Smith, J. Morris Chang, Sahana Rajasekhara |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Physical activity Phase (combat) law.invention Personalization 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Behavior Therapy law Neoplasms Intervention (counseling) Humans Pain Management Medicine 030212 general & internal medicine Medical prescription Exercise Fatigue General Nursing 030504 nursing business.industry Advanced stage Cancer medicine.disease Quality of Life Physical therapy 0305 other medical science business |
| Zdroj: | Research in Nursing & Health. 44:238-249 |
| ISSN: | 1098-240X 0160-6891 |
| DOI: | 10.1002/nur.22099 |
| Popis: | Fatigue and pain are the most frequently reported symptoms among advanced-stage cancer patients. Although physical activity (PA) is known to improve the aforementioned symptoms, few patients demonstrate the physically active behavior that adheres to the clinical guidelines regarding PA. The current article presents an exemplar that used the National Institute of Health's Obesity-Related Behavioral Intervention Trial (ORBIT) model and developed a behavioral intervention known as the personalized Physical Activity intervention with fitness graded Motion Exergames (PAfitME™). There were two phases of testing in the ORBIT model presented in the current paper. In Phase I testing, a standardized exergame prescription was evaluated by an advisory board and a single-case study was used to evaluate the personalized exergame prescription with personalization of the fitness levels. In Phase IIa, a within-group pre- and posttest design was used to evaluate the personalized exergame prescriptions with personalization of the fitness levels, self-efficacy, and variation in fatigue/pain. Subsequently, a complete intervention package was developed in accordance with a logic model, driven from the result of the Phase IIa testing with clinically significant findings. Currently, PAfitME™ is under Phase IIb testing in a randomized clinical trial with a control group. PAfitME™ employs a personalized approach to initiate and promote physically active behavior, to facilitate the management of fatigue and pain in cancer patients. Positive results from an efficacy trial would support the use of PAfitME™ in the management of fatigue and pain in advanced-stage cancer patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text